OM Stock Analysis: Buy, Sell, or Hold?
OM - Outset Medical, Inc. Common Stock
$3.63
-0.18 (-4.72%)
▼
5d:
-1.76%
30d:
-17.5%
90d:
+7.08%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Distribution
OM is up 10.4% this week, but smart money is buying puts. Top strike: $5 2026-06-18 with 1 OI. Put ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When OM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called OM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: OM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: OM is currently trading at $3.63, which is considered oversold relative to its 30-day fair value range of $3.96 to $4.60.
Technical Outlook: Technically, OM is showing sideways momentum. Immediate support is located at $3.47, while resistance sits at $4.84. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+147.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OM is showing sideways momentum. Immediate support is located at $3.47, while resistance sits at $4.84. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+147.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.96 -
$4.60
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 147.9% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$3.96 -
$4.60
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.47
Resistance Level
$4.84
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.67
Wall Street Target
$9.00
(+147.9%)
Revenue Growth (YoY)
-6.3%
Profit Margin
-63.6%
Share & Embed Analysis
Last updated: May 18, 2026 5:09 AM ET
Data refreshes hourly during market hours. Next update: 6:09 AM
Data refreshes hourly during market hours. Next update: 6:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Leslie Trigg
SELL
3361 shares
2026-02-17
Marc Nash
SELL
1817 shares
2026-02-17
John L Brottem
SELL
2842 shares
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
